Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Tri Pointe Homes, one of the largest homebuilders in the U.S., has been named to the 2026 PEOPLE Companies That Care list for the fourth consecutive year, underscoring its dedication to fostering a supportive workplace culture, employee empowerment, sustainable business practices, and community engagement. This recognition is based on extensive emp…
Haoxi Health Technology Limited announced a reverse share split of its Class A and Class B ordinary shares at a ratio of 1-for-20 effective August 14, 2026. The split will reduce the number of outstanding shares and increase the share price accordingly on Nasdaq, where the stock trades under ticker HAO. No fractional shares will be issued; fraction…
Madrigal Pharmaceuticals, a biopharmaceutical company specializing in treatments for metabolic dysfunction-associated steatohepatitis (MASH), announced the appointment of Dr. John C. Reed to its Board of Directors. Dr. Reed brings extensive leadership experience in drug discovery and development from his roles at Johnson & Johnson, Sanofi, and Roch…
Bone Biologics Corporation announces the extension of the validated shelf life of its rhNELL-1 protein to 32 months, improving flexibility in manufacturing, storage, and distribution as it advances its pilot clinical study for spinal fusion applications. This milestone supports operational efficiency and supply chain flexibility for the company's l…
Twin Disc, Inc. (NASDAQ: TWIN) announced the release date for its fiscal 2026 fourth-quarter earnings, set for August 20, 2026, along with a webcast and conference call to discuss the results. The company manufactures marine and heavy-duty off-highway power transmission equipment, serving multiple markets including marine, energy, military, and ind…
Teck Resources Limited obtained majority consents from holders of its outstanding notes to approve proposed amendments aligning debt covenants with those of Anglo American plc in anticipation of an expected merger. The consent solicitations have expired, amendments have been executed, and consent fees will be paid. The merger between Teck and Anglo…
Nexera Technologies' majority-owned subsidiary, Fort Technology Inc., has signed agreements to acquire a 50.1% stake in Logia USA, a company focused on advanced fuel integrity solutions for data centers and mission-critical facilities in the U.S. The acquisition involves issuing shares valued at $125,000 and providing a $2 million credit facility t…
3 E Network Technology Group Limited announced the completion of the initial system-level architecture specification for its next-generation customized AI storage controller and preliminary validation of its core data flow algorithms through software simulation. This progress marks a key step in the development of hardware designed to overcome Inpu…
China’s central bank said it will keep policy appropriately loose and stand ready to introduce practical measures when necessary, while not explicitly committing to cuts in policy rates or the reserve-requirement ratio. The People’s Bank of China (PBoC) pledged to use existing tools, plan additional steps, step up counter-cyclical adjustment and wo…
Rocket Lab (RKLB) is priced for growth more than profits. With record top-line momentum (Q2 revenue of $234M, ~62% YoY) and a $2.36B backlog, the company’s upcoming Neutron program milestones set the stage for margin expansion and, potentially, sustained profitability. This trade idea lays out a long entry around current levels with a clear stop an…
Legend Biotech's recent in vivo CAR-T readout and manufacturing expansion make its pipeline narrative real. Pair that with improving technicals and manageable financing, and there is a mid-term trade worth considering: enter on weakness, target the $30 area, and protect capital with a below-$18 stop.
A senior Iranian official says there have been no negotiations to prolong an interim ceasefire with the United States because Tehran views the agreement as having had no defined start date. The comment follows external reports that Tehran and Washington had agreed to extend a 60-day window under the June interim deal. Mediators are said to be discu…
Protagonist Therapeutics just cleared a major commercial hurdle with Icotyde (icotrokinra) approval and a $50M milestone payment; the stock still offers upside as the market reprices recurring-revenue potential and waits on rusfertide and other pipeline moves. This trade idea takes a long stance with a 180-trading-day horizon and a clear entry, sto…
Paramount Gold Nevada (PZG) has made measurable permitting progress at Grassy Mountain and picked up federal FAST-41 status, but audited filings with a going concern qualification and only ~$2.6M of cash leave the company exposed if capital markets turn cold. Technicals show an overbought setup while short activity has been meaningful — a setup tha…
Adagene Inc. announced its financial results for the six months ended June 30, 2026, highlighting significant clinical advancements in its lead candidate muzastotug (ADG126), a masked anti-CTLA-4 antibody. The company reported encouraging efficacy and safety data in microsatellite stable colorectal cancer (MSS CRC) and hepatocellular carcinoma (HCC…
Xilio Therapeutics announced FDA clearance of its IND application for XTX501, a bispecific PD-1/masked IL-2 therapy targeting solid tumors. The company is advancing additional masked T cell engager programs with anticipated IND submissions in 2027. Q2 financials showed increased collaboration revenue and reduced net loss, with a strong cash runway …
Nexxen International Ltd. reported record second quarter 2026 financial results, with Contribution ex-TAC of $97.8 million and programmatic revenue of $95.2 million, reflecting double-digit year-over-year growth. The company achieved an all-time record for quarterly Connected TV (CTV) revenue, up 33% year-over-year. Nexxen advanced its AI technolog…
Nexxen announced key executive appointments including Chance Johnson as President, Kara Puccinelli as Chief Commercial Officer, and Kenneth Suh as Chief Business Officer to strengthen leadership as the company scales its AI-powered unified advertising platform. These appointments aim to enhance strategic client relationships, expand enterprise grow…
Arbutus Biopharma reported a solid financial position at the end of Q2 2026, including receipt of a $178 million settlement payment from Moderna. The company filed international patent enforcement lawsuits against Pfizer and BioNTech related to its lipid nanoparticle technology. It also obtained FDA Fast Track designation for imdusiran, its hepatit…
Altimmune, Inc. announced key advancements in its late-stage clinical program for pemvidutide, targeting metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company initiated a global Phase 3 PERFORMA trial in MASH, reported positive Phase 2 topline data in AUD, and co…
Rekor Systems announced that their GoSecure platform now includes patent-pending audio verification capabilities, applying cryptographic authentication to audio recordings. This extends their technology beyond video to meet growing demands from law enforcement, courts, financial institutions, and government agencies for verifiable and tamper-proof …
PolyPid Ltd. reports FDA acceptance with Priority Review for its NDA submission of D-PLEX100 aimed at preventing surgical site infections in abdominal colorectal surgeries. The FDA PDUFA goal date is set for November 28, 2026, ahead of prior guidance, with a potential commercial launch in early 2027 under an exclusive U.S. and Canada partnership wi…
BrainsWay Ltd. reported a strong second quarter 2026 with revenue increasing 35% year-over-year to $17.1 million, a more than doubling of adjusted EBITDA to $3.5 million, and record shipments of Deep TMS systems up 42%. The company raised its full-year 2026 revenue guidance to $68-$70 million and adjusted EBITDA to $13-$14 million, citing expanding…
Ming Shing Group Holdings Limited (NASDAQ: PMA), a Hong Kong-based company focused on wet trades works and graphene technology, announced entering into a stock purchase agreement to acquire Meals Through Seasons Limited, a company controlling MTHK which operates in organic agricultural supply chain, cold chain logistics, and product processing. The…
Unicycive Therapeutics announced its Q2 2026 financial results and provided a business update highlighting progress toward FDA approval of its lead drug candidate, oxylanthanum carbonate (OLC), for treating hyperphosphatemia in dialysis patients. The FDA has assigned a facility inspection to the third-party manufacturer, a prerequisite for NDA resu…
